First runner up prize in the John Molson MBA Case Writing Competition 2006, organized by the John Molson School of Business, Concordia University, Montreal, Canada

The betapharm Acquisition: DRL's Inorganic Growth Strategy in Europe

The betapharm Acquisition: DRL's Inorganic Growth Strategy in Europe
Case Code: BSTR249
Case Length: 19 Pages
Period: 2002 - 2006
Pub Date: 2007
Teaching Note: Available
Price: Rs.500
Organization: Dr. Reddy's Laboratories Ltd.
Industry: Pharmaceutical
Countries: Germany, Europe, India
Themes: Business Strategy, Strategic Management, Mergers and Acquisitions
The betapharm Acquisition: DRL's Inorganic Growth Strategy in Europe
Abstract Case Intro 1 Case Intro 2 Excerpts

Background Note

DRL was founded by Dr. Anji Reddy (Reddy) in 1984 in the South Indian city of Hyderabad. Reddy, who hailed from an agricultural family, had a keen interest in chemical engineering and obtained a doctorate in that discipline in 1969. He worked for a short while as a scientist with the state-owned pharmaceutical company, Indian Drugs and Pharmaceuticals Limited (IDPL), in its research and development division. Reddy was known for his entrepreneurship even before he established DRL. In fact, he was involved in founding and managing two companies, Uniloids Limited and Standard Organics Limited, during the period 1976 to 1984, prior to establishing DRL....

Buy this case study (Please select any one of the payment options)

Price: Rs.500
Price: Rs.500
PayPal (11 USD)

Custom Search